Literature DB >> 26696614

Seeking safe stool: Canada needs a universal donor model.

Carolyn Edelstein1, Jamie R Daw2, Zain Kassam2.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26696614      PMCID： PMC5135517          DOI： 10.1503/cmaj.150672

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  9 in total

1.  Faecal microbiota transplant for recurrent Clostridium difficile infection using long-term frozen stool is effective: clinical efficacy and bacterial viability data.

Authors:  S P Costello; M A Conlon; M S Vuaran; I C Roberts-Thomson; J M Andrews
Journal:  Aliment Pharmacol Ther       Date:  2015-08-11       Impact factor: 8.171

2.  Stool colonization of healthcare workers with selected resistant bacteria.

Authors:  Y Carmeli; L Venkataraman; P C DeGirolami; D A Lichtenberg; A W Karchmer; M H Samore
Journal:  Infect Control Hosp Epidemiol       Date:  1998-01       Impact factor: 3.254

Review 3.  Review of the emerging treatment of Clostridium difficile infection with fecal microbiota transplantation and insights into future challenges.

Authors:  Zain Kassam; Christine H Lee; Richard H Hunt
Journal:  Clin Lab Med       Date:  2014-09-30       Impact factor: 1.935

4.  Canadian Association of Gastroenterology position statement: fecal microbiota transplant therapy.

Authors:  Paul Moayyedi; John K Marshall; Yuhong Yuan; Richard Hunt
Journal:  Can J Gastroenterol Hepatol       Date:  2014-02

5.  Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection.

Authors:  Lawrence J Brandt; Olga C Aroniadis; Mark Mellow; Amy Kanatzar; Colleen Kelly; Tina Park; Neil Stollman; Faith Rohlke; Christina Surawicz
Journal:  Am J Gastroenterol       Date:  2012-03-27       Impact factor: 10.864

6.  Duodenal infusion of donor feces for recurrent Clostridium difficile.

Authors:  Els van Nood; Anne Vrieze; Max Nieuwdorp; Susana Fuentes; Erwin G Zoetendal; Willem M de Vos; Caroline E Visser; Ed J Kuijper; Joep F W M Bartelsman; Jan G P Tijssen; Peter Speelman; Marcel G W Dijkgraaf; Josbert J Keller
Journal:  N Engl J Med       Date:  2013-01-16       Impact factor: 91.245

7.  Cost-effectiveness of competing strategies for management of recurrent Clostridium difficile infection: a decision analysis.

Authors:  Gauree G Konijeti; Jenny Sauk; Mark G Shrime; Meera Gupta; Ashwin N Ananthakrishnan
Journal:  Clin Infect Dis       Date:  2014-03-31       Impact factor: 9.079

Review 8.  Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis.

Authors:  Zain Kassam; Christine H Lee; Yuhong Yuan; Richard H Hunt
Journal:  Am J Gastroenterol       Date:  2013-03-19       Impact factor: 10.864

9.  Incidence and Costs of Clostridium difficile Infections in Canada.

Authors:  Adrian R Levy; Shelagh M Szabo; Greta Lozano-Ortega; Elisa Lloyd-Smith; Victor Leung; Robin Lawrence; Marc G Romney
Journal:  Open Forum Infect Dis       Date:  2015-06-03       Impact factor: 3.835
  9 in total
  7 in total

Review 1.  Scaling Safe Access to Fecal Microbiota Transplantation: Past, Present, and Future.

Authors:  Ryan Eliott; Pratik Panchal; Shrish Budree; Alex Scheeler; Geraldine Medina; Monica Seng; Wing Fei Wong; Thomas Mitchell; Zain Kassam; Jessica R Allegretti; Majdi Osman
Journal:  Curr Gastroenterol Rep       Date:  2018-03-28

Review 2.  Fecal Microbiota Transplantation Donor Screening Updates and Research Gaps for Solid Organ Transplant Recipients.

Authors:  Nirja Mehta; Tiffany Wang; Rachel J Friedman-Moraco; Cynthia Carpentieri; Aneesh K Mehta; Nadine Rouphael; Tanvi Dhere; Christian P Larsen; Colleen S Kraft; Michael H Woodworth
Journal:  J Clin Microbiol       Date:  2021-06-16       Impact factor: 11.677

Review 3.  International consensus conference on stool banking for faecal microbiota transplantation in clinical practice.

Authors:  Giovanni Cammarota; Gianluca Ianiro; Colleen R Kelly; Benjamin H Mullish; Jessica R Allegretti; Zain Kassam; Lorenza Putignani; Monika Fischer; Josbert J Keller; Samuel Paul Costello; Harry Sokol; Patrizia Kump; Reetta Satokari; Stacy A Kahn; Dina Kao; Perttu Arkkila; Ed J Kuijper; Maria J Gt Vehreschild; Cristina Pintus; Loris Lopetuso; Luca Masucci; Franco Scaldaferri; E M Terveer; Max Nieuwdorp; Antonio López-Sanromán; Juozas Kupcinskas; Ailsa Hart; Herbert Tilg; Antonio Gasbarrini
Journal:  Gut       Date:  2019-09-28       Impact factor: 23.059

4.  In search of stool donors: a multicenter study of prior knowledge, perceptions, motivators, and deterrents among potential donors for fecal microbiota transplantation.

Authors:  Breanna McSweeney; Jessica R Allegretti; Monika Fischer; Huiping Xu; Karen J Goodman; Tanya Monaghan; Carmen McLeod; Benjamin H Mullish; Elaine O Petrof; Emmalee L Phelps; Roxana Chis; Abby Edmison; Angela Juby; Ralph Ennis-Davis; Brandi Roach; Karen Wong; Dina Kao
Journal:  Gut Microbes       Date:  2019-05-23

5.  Determinants of community members' willingness to donate stool for faecal microbiota transplantation.

Authors:  Melissa K Hyde; Barbara M Masser
Journal:  PLoS One       Date:  2020-12-10       Impact factor: 3.240

6.  Reorganisation of faecal microbiota transplant services during the COVID-19 pandemic.

Authors:  Gianluca Ianiro; Benjamin H Mullish; Colleen R Kelly; Zain Kassam; Ed J Kuijper; Siew C Ng; Tariq H Iqbal; Jessica R Allegretti; Stefano Bibbò; Harry Sokol; Faming Zhang; Monika Fischer; Samuel Paul Costello; Josbert J Keller; Luca Masucci; Joffrey van Prehn; Gianluca Quaranta; Mohammed Nabil Quraishi; Jonathan Segal; Dina Kao; Reetta Satokari; Maurizio Sanguinetti; Herbert Tilg; Antonio Gasbarrini; Giovanni Cammarota
Journal:  Gut       Date:  2020-07-03       Impact factor: 23.059

7.  Fecal microbiota transplantation in inflammatory bowel disease patients: A systematic review and meta-analysis.

Authors:  Luciane de Fátima Caldeira; Helena H Borba; Fernanda S Tonin; Astrid Wiens; Fernando Fernandez-Llimos; Roberto Pontarolo
Journal:  PLoS One       Date:  2020-09-18       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.